Bayer ( OTCPK:BAYZF) ( OTCPK:BAYRY) dropped significantly after a Georgia state jury ordered the company to pay $2.1 billion in a case involving its Roundup weedkiller. The decision, delivered in Cobb ...
For decades, aspirin has been known as a go-to painkiller. New research reveals how it may also help fight cancer. While previous research hinted at a link between aspirin use and improved cancer ...
Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...
The following is a summary of “Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a ...
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's ...
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court ...
Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...
Bayer, a biomedical and pharmaceutical behemoth, makes drugs such as aspirin, Claritin and Aleve. In recent years, the company has come under heightened scrutiny after it acquired agrochemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback